Skip to main content
The BMJ logoLink to The BMJ
letter
. 1995 Feb 4;310(6975):330–331. doi: 10.1136/bmj.310.6975.330a

Apolipoprotein e4 allele and cognitive decline. May be less relevant.

G B Frisoni, A Bianchetti, G Franceschini, S Govoni, M Trabucchi
PMCID: PMC2548720  PMID: 7755725

Full text

PDF

Page 330

330

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Corder E. H., Saunders A. M., Risch N. J., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Jr, Rimmler J. B., Locke P. A., Conneally P. M., Schmader K. E. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet. 1994 Jun;7(2):180–184. doi: 10.1038/ng0694-180. [DOI] [PubMed] [Google Scholar]
  2. Feskens E. J., Havekes L. M., Kalmijn S., de Knijff P., Launer L. J., Kromhout D. Apolipoprotein e4 allele and cognitive decline in elderly men. BMJ. 1994 Nov 5;309(6963):1202–1206. doi: 10.1136/bmj.309.6963.1202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Frisoni G. B., Bianchetti A., Govoni S., Trabucchi M., Calabresi L., Franceschini G. Association of apolipoprotein E E4 with vascular dementia. JAMA. 1994 May 4;271(17):1317–1317. [PubMed] [Google Scholar]
  4. Payami H., Kaye J., Heston L. L., Bird T. D., Schellenberg G. D. Apolipoprotein E genotype and Alzheimer's disease. Lancet. 1993 Sep 18;342(8873):738–738. [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES